203 related articles for article (PubMed ID: 23593453)
21. Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats.
Joyce C; Scallan CD; Mateo R; Belshe RB; Tucker SN; Moore AC
Vaccine; 2018 Jul; 36(29):4265-4277. PubMed ID: 29895499
[TBL] [Abstract][Full Text] [Related]
22. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
[TBL] [Abstract][Full Text] [Related]
23. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
24. Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
Cayatte C; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; McTamney P; Ren K; O'Day T; McCarthy MP; Schneider-Ohrum K
PLoS One; 2017; 12(11):e0188708. PubMed ID: 29182682
[TBL] [Abstract][Full Text] [Related]
25. Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu YH; He JS; Qiao W; Jiao YY; Hua Y; Zhang Y; Peng XL; Hong T
Virol J; 2013 Jun; 10():183. PubMed ID: 23742026
[TBL] [Abstract][Full Text] [Related]
26. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
[TBL] [Abstract][Full Text] [Related]
27. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
Valosky J; Hishiki H; Zaoutis TE; Coffin SE
Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003
[TBL] [Abstract][Full Text] [Related]
28. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
29. Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model.
Eberlein V; Ahrends M; Bayer L; Finkensieper J; Besecke JK; Mansuroglu Y; Standfest B; Lange F; Schopf S; Thoma M; Dressman J; Hesse C; Ulbert S; Grunwald T
Viruses; 2023 Aug; 15(9):. PubMed ID: 37766253
[TBL] [Abstract][Full Text] [Related]
30. A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant.
Zhao B; Yang J; He B; Li X; Yan H; Liu S; Yang Y; Zhou D; Liu B; Fan X; Zhong M; Zhang E; Zhang F; Zhang Y; Chen YQ; Jiang S; Yan H
Cell Rep; 2021 Jul; 36(3):109401. PubMed ID: 34289371
[TBL] [Abstract][Full Text] [Related]
31. C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.
Cyr SL; Jones T; Stoica-Popescu I; Burt D; Ward BJ
Vaccine; 2007 Apr; 25(16):3228-32. PubMed ID: 17374422
[TBL] [Abstract][Full Text] [Related]
32. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
[TBL] [Abstract][Full Text] [Related]
33. Neonatal immunization with respiratory syncytial virus glycoprotein fragment induces protective immunity in the presence of maternal antibodies in mice.
Noh Y; Shim BS; Cheon IS; Rho S; Kim HJ; Choi Y; Kang CY; Chang J; Song MK; Kim JO
Viral Immunol; 2013 Aug; 26(4):268-76. PubMed ID: 23869549
[TBL] [Abstract][Full Text] [Related]
34. Nod2 downregulates TLR2/1 mediated IL1β gene expression in mouse peritoneal macrophages.
Dahiya Y; Pandey RK; Sodhi A
PLoS One; 2011; 6(11):e27828. PubMed ID: 22114704
[TBL] [Abstract][Full Text] [Related]
35. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
McGinnes Cullen L; Schmidt MR; Morrison TG
J Virol; 2019 May; 93(9):. PubMed ID: 30760576
[TBL] [Abstract][Full Text] [Related]
36. Respiratory syncytial virus infection augments NOD2 signaling in an IFN-β-dependent manner in human primary cells.
Vissers M; Remijn T; Oosting M; de Jong DJ; Diavatopoulos DA; Hermans PW; Ferwerda G
Eur J Immunol; 2012 Oct; 42(10):2727-35. PubMed ID: 22730064
[TBL] [Abstract][Full Text] [Related]
37. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines.
Crowe JE; Firestone CY; Murphy BR
J Immunol; 2001 Oct; 167(7):3910-8. PubMed ID: 11564809
[TBL] [Abstract][Full Text] [Related]
38. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
Eichinger KM; Kosanovich JL; Gidwani SV; Zomback A; Lipp MA; Perkins TN; Oury TD; Petrovsky N; Marshall CP; Yondola MA; Empey KM
Front Immunol; 2020; 11():1673. PubMed ID: 32849580
[TBL] [Abstract][Full Text] [Related]
39. NOD2 up-regulates TLR2-mediated IL-23p19 expression via NF-κB subunit c-Rel in Paneth cell-like cells.
Tan G; Liang E; Liao K; Deng F; Zhang W; Chen Y; Xu J; Zhi F
Oncotarget; 2016 Sep; 7(39):63651-63660. PubMed ID: 27563808
[TBL] [Abstract][Full Text] [Related]
40. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
Antiviral Res; 2018 Oct; 158():78-87. PubMed ID: 30071204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
